-
Signature
-
/s/ Charles Schoch, as Attorney-In-Fact for William Garrett Nichols
-
Issuer symbol
-
CADL
-
Transactions as of
-
28 Jul 2025
-
Net transactions value
-
-$5,332
-
Form type
-
4
-
Filing time
-
30 Jul 2025, 16:30:16 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Nichols William Garrett |
Chief Medical Officer |
C/O CANDEL THERAPEUTICS, INC., 117 KENDRICK ST., SUITE 450, NEEDHAM |
/s/ Charles Schoch, as Attorney-In-Fact for William Garrett Nichols |
30 Jul 2025 |
0001618364 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CADL |
Common Stock |
Options Exercise |
$1,209 |
+937 |
+1.8% |
$1.29 |
53,430 |
28 Jul 2025 |
Direct |
F1 |
| transaction |
CADL |
Common Stock |
Sale |
$6,540 |
-937 |
-1.8% |
$6.98 |
52,493 |
28 Jul 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CADL |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-937 |
-3.1% |
$0.000000 |
29,377 |
28 Jul 2025 |
Common Stock |
937 |
$1.29 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: